Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
作者信息
Soubrane G, Bressler N M
机构信息
Clinique Ophtalmologique Universitaire de Créteil, Université Paris-Val-de-Marne, Créteil, France.
出版信息
Br J Ophthalmol. 2001 Apr;85(4):483-95. doi: 10.1136/bjo.85.4.483.
Abstract
摘要
相似文献
1
Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.年龄相关性黄斑变性中黄斑下脉络膜新生血管的治疗：聚焦维替泊芬光动力疗法的临床应用
Br J Ophthalmol. 2001 Apr;85(4):483-95. doi: 10.1136/bjo.85.4.483.
2
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.维替泊芬：其在治疗黄斑中心凹下脉络膜新生血管中的应用综述
Drugs. 2003;63(22):2521-54. doi: 10.2165/00003495-200363220-00016.
3
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
Am J Ophthalmol. 2002 Jan;133(1):168-9. doi: 10.1016/s0002-9394(01)01237-5.
4
Retinal translocation and photodynamic therapy for age-related macular degeneration with classic choroidal neovascularization: a clinicopathologic case report.
Retina. 2002 Dec;22(6):818-24. doi: 10.1097/00006982-200212000-00027.
5
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管：两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法（TAP）研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
6
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管
Am J Ophthalmol. 2002 Jun;133(6):857; author reply 857-9. doi: 10.1016/s0002-9394(02)01423-x.
7
Verteporfin ocular photodynamic therapy.维替泊芬眼部光动力疗法
Expert Opin Pharmacother. 2004 Jan;5(1):195-203. doi: 10.1517/14656566.5.1.195.
8
Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration.维替泊芬光动力疗法对特定的新生血管性年龄相关性黄斑变性患者有效。
Arch Ophthalmol. 1999 Oct;117(10):1400-2. doi: 10.1001/archopht.117.10.1400.
9
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: from clinical trials to clinical practice.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管：从临床试验到临床实践
Semin Ophthalmol. 2001 Dec;16(4):207-12. doi: 10.1076/soph.16.4.207.10296.
10
Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin.维替泊芬光动力疗法时代对近黄斑中心凹和黄斑中心凹外脉络膜新生血管的治疗
Am J Ophthalmol. 2002 Jul;134(1):99-101. doi: 10.1016/s0002-9394(02)01463-0.
引用本文的文献
1
Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review.维替泊芬光动力疗法治疗脉络膜视网膜疾病：一项叙述性综述
Clin Ophthalmol. 2024 Jun 10;18:1701-1716. doi: 10.2147/OPTH.S464371. eCollection 2024.
2
Application and investigation of thrombopoiesis-stimulating agents in the treatment of thrombocytopenia.血小板生成刺激剂在血小板减少症治疗中的应用与研究
Ther Adv Hematol. 2023 Feb 27;14:20406207231152746. doi: 10.1177/20406207231152746. eCollection 2023.
3
Sustained-Release Microspheres of Rivoceranib for the Treatment of Subfoveal Choroidal Neovascularization.用于治疗黄斑下脉络膜新生血管的瑞戈非尼缓释微球
Pharmaceutics. 2021 Sep 24;13(10):1548. doi: 10.3390/pharmaceutics13101548.
4
Plasmonic Gold Nanostar-Enhanced Multimodal Photoacoustic Microscopy and Optical Coherence Tomography Molecular Imaging To Evaluate Choroidal Neovascularization.等离子体金纳米星增强多模态光声显微镜和光学相干断层扫描分子成像用于评估脉络膜新生血管形成。
ACS Sens. 2020 Oct 23;5(10):3070-3081. doi: 10.1021/acssensors.0c00908. Epub 2020 Sep 30.
5
Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.增强基于视网膜色素上皮细胞的年龄相关性黄斑变性治疗效果：布鲁赫膜的作用。
Transl Vis Sci Technol. 2014 Jul 3;3(3):11. doi: 10.1167/tvst.3.3.11. eCollection 2014 Jun.
6
25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina.第 25 届 RCOphth 大会，主席会议论文：医学视网膜 25 年的进展。
Eye (Lond). 2014 Sep;28(9):1041-52. doi: 10.1038/eye.2014.141. Epub 2014 Jul 4.
7
Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life.光动力疗法治疗年龄相关性黄斑变性对主观视觉相关生活质量的影响。
Graefes Arch Clin Exp Ophthalmol. 2006 Aug;244(8):972-7. doi: 10.1007/s00417-005-0218-x. Epub 2006 Jan 13.
8
Age-related macular degeneration.年龄相关性黄斑变性
Ulster Med J. 2005 Sep;74(2):82-92.
9
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisation.维替泊芬：其在治疗黄斑中心凹下脉络膜新生血管中的应用综述
Drugs. 2003;63(22):2521-54. doi: 10.2165/00003495-200363220-00016.
10
Giant neurosensory detachments associated with disciform lesions in neovascular age related macular degeneration.新生血管性年龄相关性黄斑变性中与盘状病变相关的巨大神经感觉层脱离
Br J Ophthalmol. 2003 Jun;87(6):795-6. doi: 10.1136/bjo.87.6.795-a.
本文引用的文献
1
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.一项使用维替泊芬进行光动力疗法治疗病理性近视、眼组织胞浆菌病综合征、血管样条纹和特发性病因所致脉络膜新生血管的初步研究。
Arch Ophthalmol. 2000 Mar;118(3):327-36. doi: 10.1001/archopht.118.3.327.
2
Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.黄斑疾病中的阈下（视网膜色素上皮）光凝：一项初步研究。
Br J Ophthalmol. 2000 Jan;84(1):40-7. doi: 10.1136/bjo.84.1.40.
3
A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration.一项关于新生血管性年龄相关性黄斑变性放射治疗的前瞻性、随机、双盲试验（RAD研究）。年龄相关性黄斑变性的放射治疗。
Ophthalmology. 1999 Dec;106(12):2239-47. doi: 10.1016/s0161-6420(99)90522-5.
4
Laser treatment in eyes with drusen.针对患有玻璃膜疣的眼睛进行激光治疗。
Curr Opin Ophthalmol. 1999 Jun;10(3):204-8. doi: 10.1097/00055735-199906000-00009.
5
Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.维替泊芬光动力疗法对食蟹猴正常视网膜和脉络膜的再治疗
Ophthalmology. 1999 Oct;106(10):1915-23. doi: 10.1016/S0161-6420(99)90401-3.
6
Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.年龄相关性黄斑变性患者隐匿性黄斑中心凹下脉络膜新生血管的经瞳孔温热疗法
Ophthalmology. 1999 Oct;106(10):1908-14. doi: 10.1016/S0161-6420(99)90400-1.
7
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.维替泊芬光动力疗法治疗年龄相关性黄斑变性引起的脉络膜新生血管：1期和2期研究中的再次治疗结果
Arch Ophthalmol. 1999 Sep;117(9):1177-87. doi: 10.1001/archopht.117.9.1177.
8
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.维替泊芬光动力疗法治疗年龄相关性黄斑变性引起的脉络膜新生血管：1期和2期单治疗研究结果
Arch Ophthalmol. 1999 Sep;117(9):1161-73. doi: 10.1001/archopht.117.9.1161.
9
Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.使用维替泊芬的光动力疗法对治疗后长达7周的实验性脉络膜新生血管以及正常视网膜和脉络膜的影响。
Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2322-31.
10
Pattern electrical stimulation of the human retina.人类视网膜的模式电刺激。
Vision Res. 1999 Jul;39(15):2569-76. doi: 10.1016/s0042-6989(99)00052-8.
Zotero 插件